GlassScriptPhysician profile
Brian Mckinley Long
NPI 1134110257
$23,960.93
in general payments reported to CMS, 2019-2025
11 companies · $5,915 in 2025
The $5,915 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,677 · 2020: $3,208 · 2021: $131 · 2022: $1,498 · 2023: $1,582 · 2024: $6,951 · 2025: $5,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,703 · Food and Beverage: $4,236 · Education: $2,500 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,703.20 |
| Food and Beverage | $4,235.98 |
| Education | $2,500.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,509.36 | 2019-2025 | |
| Medtronic, INC. | $5,561.22 | 2022-2025 | Signia, Ligasure, Sonicision |
| Medical Device Business Services, INC. | $1,895.26 | 2025 | |
| Covidien LP | $825.80 | 2019 | |
| W. L. Gore & Associates, INC. | $521.62 | 2019-2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Ethicon US, LLC | $505.40 | 2021-2025 | Echelon; Endopath, Vistaseal, Linx Reflux Management System |
| Apollo Endosurgery US INC | $41.22 | 2019 | |
| Boston Scientific Corporation | $30.85 | 2023 | Wavewriter Alpha Prime 16 |
| Endo Pharmaceuticals INC. | $27.53 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.68 | 2025 | Exparel |
| Olympus America INC. | $18.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.